Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme [Epub ahead of print]
Publication Type:
Journal Article
Authors:
Christophe Hézode;
Lebray, Pascal;
V de Ledinghen;
Zoulim, Fabien;
Di Martino, Vincent;
Boyer, Nathalie;
Larrey, Dominique;
Botta-Fridlund, Danielle;
Silvain, Christine;
Fontaine, Helene;
D'Alteroche, Louis;
Vincent Leroy;
Bourliere, Marc;
Hubert-Fouchard, Isabelle;
Guyader, Dominique;
Rosa, Isabelle;
Nguyen-Khac, Eric;
Fedchuk, Larysa;
Akremi, Raoudha;
Bennai, Yacia;
Filipovics, Anne;
Zhao, Yue;
Bronowicki, Jean-PierreSource:
Liver Int, Volume 37, Issue 9, p.1314-1324 (2017)
Keywords:
compassionate use,
daclatasvir,
genotype 3,
Hepatitis C,
real-world data,
sofosbuvir
